Table 1 Characteristics of subjects
From: Glucagon-like peptide 1 improved glycemic control in type 1 diabetes
Dose Study | 8-Hour Study | 5-Day Study | |
|---|---|---|---|
N | 15 | 9 | 8 |
Sex | 9M/6F | 4M/5F | 5M/3F |
Age, y | 40 ± 4 | 36 ± 5 | 34 ± 3 |
BMI | 24.6 ± 0.9 | 24.7 ± 0.9 | 25.4 ± 1.3 |
Duration of T1D, y | 16 ± 3 | 18 ± 5 | 15 ± 4 |
Insulin dose, U/kg/d | 0.66 ± 0.10 | 0.79 ± 0.15 | 0.73 ± 0.07 |
Fasting glucose, mmol/l | 5.9 ± 0.5 | 5.5 ± 0.6 | 6.9 ± 0.6 |
A1c, % | 6.5 ± 0.3 | 6.5 ± 0.3 | 6.5 ± 0.4 |